Affiliation:
1. Department of Radiation Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06273, Republic of Korea
2. Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul 03722, Republic of Korea
Abstract
The purpose of this study is to evaluate RadCalc, an independent dose verification software, for patient-specific quality assurance (PSQA) in online adaptive planning with a magnetic resonance linear accelerator (MR-linac) of a 1.5 T. Version 7.1.4 of RadCalc to introduce the capability to establish a beam model that incorporates MR field characteristics. A total of six models were established, with one using manufacturer-provided data and the others differing in percentage depth dose (PDD) data sources. Overall, two models utilized PDD data from the treatment planning system (TPS), and three used commissioned PDD data from gantry angles of 0° and 270°. Simple tests on a virtual water phantom assessed dose-calculation accuracy, revealing percentage differences ranging from −0.5% to −20.6%. Excluding models with significant differences, clinical tests on 575 adaptive plans (prostate, liver, and breast) showed percentage differences of −0.51%, 1.12%, and 4.10%, respectively. The doses calculated using RadCalc demonstrated similar trends to those of the PSQA-based measurements. The newly released version of RadCalc enables beam modeling that considers the characteristics of the 1.5 T magnetic field. The accuracy of the software in calculating doses at 1.5 T magnetic fields has been verified, thereby making it a reliable and effective tool for PSQA in adaptive plans.
Funder
Yonsei University College of Medicine
the National Research Foundation of Korea
Reference32 articles.
1. MR-Guided Radiotherapy for Brain and Spine Tumors;Maziero;Front. Oncol.,2021
2. MR-guided radiotherapy for liver malignancies;Boldrini;Front. Oncol.,2021
3. Rammohan, N., Randall, J.W., and Yadav, P. (2022). History of technological advancements towards MR-Linac: The future of image-guided radiotherapy. J. Clin. Med., 11.
4. Compact bunker shielding assessment for 1.5 T MR-Linac;Sung;Sci. Rep.,2022
5. Medical physics challenges in clinical MR-guided radiotherapy;Kurz;Radiat. Oncol.,2020